| Not Yet Recruiting | The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC Ulcerative Colitis (UC) | Phase 2 | 2026-03-31 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis ( Axial Spondyloarthritis, Non-Radiographic | Phase 3 | 2026-03-09 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) Ankylosing Spondylitis | Phase 3 | 2025-11-07 |
| Recruiting | The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE Systemic Lupus Erythematosus (SLE) | Phase 1 / Phase 2 | 2025-09-24 |
| Recruiting | Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 3 | 2025-08-05 |
| Not Yet Recruiting | Evaluation of 627 in Healthy Adult Subjects Healthy Subjects (HS) | Phase 1 | 2025-07-20 |
| Recruiting | Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Pulmonary Disease, Chronic Obstructive (COPD) | Phase 3 | 2025-07-16 |
| Not Yet Recruiting | A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China Atopic Dermatitis | Phase 1 | 2025-07-01 |
| Active Not Recruiting | A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma Asthma | Phase 2 | 2024-12-20 |
| Recruiting | Evaluation of 626 in Healthy Adult Subjects Healthy Subjects (HS) | Phase 1 | 2024-12-02 |
| Active Not Recruiting | A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps Sinusitis, Nasal Polyps | Phase 3 | 2024-11-22 |
| Recruiting | A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer | Phase 2 | 2024-10-10 |
| Active Not Recruiting | Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic De Dermatitis, Atopic, Eczema, Atopic | Phase 3 | 2024-09-23 |
| Recruiting | A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients Metastatic Colorectal Cancer | Phase 2 | 2024-09-03 |
| Not Yet Recruiting | Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Advanced Solid Tumors Patients | Phase 1 | 2024-08-01 |
| Recruiting | A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients First-line Advanced NSCLC Patients | Phase 2 | 2024-07-26 |
| Active Not Recruiting | Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 1 / Phase 2 | 2024-07-10 |
| Recruiting | Efficacy and Safety Study of 610 in Patients With Severe Asthma Asthma | Phase 3 | 2024-06-24 |
| Recruiting | A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Locally Advanced, Recurrent or Metastatic Malignancies | Phase 1 | 2024-05-30 |
| Recruiting | A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients NSCLC | Phase 2 | 2024-05-15 |
| Unknown | An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO Plaque Psoriasis Patients | Phase 3 | 2024-05-15 |
| Unknown | A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment. Gout Arthritis | Phase 2 | 2024-03-30 |
| Recruiting | A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) Axial Spondyloarthritis | Phase 2 | 2024-03-22 |
| Unknown | A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS) Ankylosing Spondylitis | Phase 2 | 2024-03-19 |
| Completed | Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Dermatitis, Atopic | Phase 3 | 2024-01-22 |
| Completed | Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease Pulmonary Disease, Chronic Obstructive | Phase 2 | 2023-12-08 |
| Unknown | A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute G Acute Gout | Phase 3 | 2023-12-01 |
| Unknown | The MAD Study of SSGJ-613 in Healthy Subjects Arthritis, Gouty | Phase 1 | 2023-08-10 |
| Unknown | A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps Sinusitis, Nasal Polyps, Polyps | Phase 2 | 2023-06-30 |
| Completed | A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate Psoriasis | Phase 3 | 2023-01-07 |
| Completed | A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss Branch Retinal Vein Occlusion | Phase 3 | 2022-12-27 |
| Completed | Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2022-10-26 |
| Unknown | A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma Asthma | Phase 2 | 2022-09-01 |
| Unknown | A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants Acute Gout | Phase 1 / Phase 2 | 2022-06-29 |
| Unknown | A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma Sarcoma, Soft Tissue | Phase 2 | 2022-01-25 |
| Unknown | A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Sarcoma, Soft Tissue | Phase 2 | 2021-12-30 |
| Unknown | A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Asthma | Phase 1 | 2021-12-06 |
| Unknown | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Pat Receptor, ErbB-2 | Phase 1 | 2021-12-01 |
| Completed | Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis Dermatitis, Atopic | Phase 1 / Phase 2 | 2021-10-18 |
| Unknown | Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection Systemic Juvenile Idiopathic Arthritis, Periodic Fever Syndrome | Phase 1 | 2021-08-13 |
| Unknown | 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV) Pathological Myopic Choroidal Neovascularization | Phase 2 | 2021-06-04 |
| Unknown | A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate Psoriasis | Phase 2 | 2021-04-01 |
| Completed | 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) Branch Retinal Vein Occlusion | Phase 2 | 2021-01-28 |
| Completed | 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) Central Retinal Vein Occlusion | Phase 2 | 2021-01-27 |
| Unknown | Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF Metastatic Colorectal Cancer | Phase 2 | 2020-12-07 |
| Completed | Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Healthy | Phase 1 | 2020-09-09 |
| Unknown | Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China Solid Tumors | N/A | 2020-07-25 |
| Unknown | Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma | Phase 1 | 2020-06-12 |
| Unknown | Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects Moderate to Severe Plaque Psoriasis | Phase 1 | 2019-11-25 |
| Unknown | Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A Solid Tumors | Phase 1 | 2019-05-01 |
| Unknown | The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) Diabetic Macular Edema | Phase 1 | 2019-03-08 |
| Unknown | Pharmacokinetics, Efficacy and Safety of the 304 Injection CD20 Positive B Cell NHL | Phase 1 | 2018-12-18 |
| Unknown | The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD) Wet Age-related Macular Degeneration | Phase 1 | 2018-11-12 |
| Unknown | A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 | 2017-11-15 |
| Completed | Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis Ankylosing Spondylitis | Phase 3 | 2014-03-06 |